Concepedia

Büsra Öztürk Akcora

BÖ

Statistics

Publications

4

Citations

201

H-Index

4

Active since

2017

Affiliations

University of Twente(Current)

Utrecht University

University of Groningen

Büsra Öztürk Akcora is an author at University of Twente specializing in hepatic fibrosis, fibrosis, and inflammation.

Publications per year

2017–2019

4

Publications

4

Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12

Büsra Öztürk Akcora, Gert Storm, Ruchi Bansal · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2017 · 95 citations · Full text

Life Sciences, Molecular Biology, Pathobiology +17

Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model

Büsra Öztürk Akcora, Gert Storm, Jai Prakash et al. · Scientific Reports · 2017 · 59 citations · Full text

Medicine, Pharmacology, Cancer Pharmacology +13

Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells

Büsra Öztürk Akcora, Alexandros Vassilios Gabriël, Ana Ortiz‐Perez et al. · FASEB BioAdvances · 2019 · 27 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +17

TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis <i>in vivo</i>

Büsra Öztürk Akcora, Eshwari Dathathri, Ana Ortiz‐Perez et al. · The FASEB Journal · 2019 · 20 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

1–4 of 4